Menlo Park, CA · Founded 2020 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to develop therapies for organ dysfunction. OrsoBio is based in Menlo Park, CA and was founded in 2020. Its last known valuation is $310 million. It has raised $167 million across 2 recorded rounds; the latest was a $40 million early-stage round in Aug 2024.
Last price · $/share
—
Implied valuation
$310.0M
Total raised
$166.6M
Last round
Early Stage VC
Aug 2024
Team — not yet on record
No current team members for OrsoBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OrsoBio with a free account
·Watch OrsoBio: the Monday email on marks, rounds and moves
